Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel V T Catenacci

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Future Oncology (London, England)|February 3, 2016
How can next-generation diagnostics aid pancreatic adenocarcinoma treatment?Shuang Qin Zhang, Daniel V T Catenacci
Hematology/Oncology Clinics of North America|May 15, 2017
Update on Gastroesophageal Adenocarcinoma Targeted TherapiesSteven B Maron, Daniel V T Catenacci
Discovery Medicine|August 1, 2012
Toward personalized treatment of advanced biliary tract cancersDaniel M Geynisman, Daniel V T Catenacci
Cancer Discovery|February 10, 2019
Variety Is the Spice of Life, but Maybe Not in Gastroesophageal AdenocarcinomasSamuel J Klempner, Daniel V T Catenacci
Biometrics|October 25, 2016
A subgroup cluster-based Bayesian adaptive design for precision medicineWentian Guo, Yuan Ji, Daniel V T Catenacci
Cancers|December 10, 2021
Immune-Checkpoint Inhibition in the Treatment of Gastro-Esophageal Cancer: A Closer Look at the Emerging EvidenceKoosha Paydary, Natalie Reizine, Daniel V T Catenacci
Seminars in Oncology|March 23, 2011
Molecular profiling of cancer--the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinicThomas Stricker, Daniel V T Catenacci, Tanguy Y Seiwert
JAMA Network Open|May 4, 2019
Keeping Checkpoint Inhibitors in CheckDaniel V T Catenacci, Howard Hochster, Samuel J Klempner
Journal of the Royal Statistical Society. Series C, Applied Statistics|June 14, 2019
AAA: triple adaptive Bayesian designs for the identification of optimal dose combinations in dual-agent dose finding trialsJiaying Lyu, Yuan Ji, Naiqing Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2019
The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is NowPadma Sheila Rajagopal, Daniel V T Catenacci, Olufunmilayo I Olopade
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Future Oncology (London, England)|February 3, 2016
How can next-generation diagnostics aid pancreatic adenocarcinoma treatment?Shuang Qin Zhang, Daniel V T Catenacci
Hematology/Oncology Clinics of North America|May 15, 2017
Update on Gastroesophageal Adenocarcinoma Targeted TherapiesSteven B Maron, Daniel V T Catenacci
Discovery Medicine|August 1, 2012
Toward personalized treatment of advanced biliary tract cancersDaniel M Geynisman, Daniel V T Catenacci
Cancer Discovery|February 10, 2019
Variety Is the Spice of Life, but Maybe Not in Gastroesophageal AdenocarcinomasSamuel J Klempner, Daniel V T Catenacci
Biometrics|October 25, 2016
A subgroup cluster-based Bayesian adaptive design for precision medicineWentian Guo, Yuan Ji, Daniel V T Catenacci
Cancers|December 10, 2021
Immune-Checkpoint Inhibition in the Treatment of Gastro-Esophageal Cancer: A Closer Look at the Emerging EvidenceKoosha Paydary, Natalie Reizine, Daniel V T Catenacci
Seminars in Oncology|March 23, 2011
Molecular profiling of cancer--the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinicThomas Stricker, Daniel V T Catenacci, Tanguy Y Seiwert
JAMA Network Open|May 4, 2019
Keeping Checkpoint Inhibitors in CheckDaniel V T Catenacci, Howard Hochster, Samuel J Klempner
Journal of the Royal Statistical Society. Series C, Applied Statistics|June 14, 2019
AAA: triple adaptive Bayesian designs for the identification of optimal dose combinations in dual-agent dose finding trialsJiaying Lyu, Yuan Ji, Naiqing Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2019
The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is NowPadma Sheila Rajagopal, Daniel V T Catenacci, Olufunmilayo I Olopade
Pageof 7